
Apixaban
Apixaban (CAS No: 503612-47-3) is produced by Amber Lifesciences Pvt. Ltd. in world-class GMP and ISO 9001:2015 certified manufacturing facilities, ensuring superior purity, consistent quality, and adherence to international regulatory standards. Each batch is provided with a detailed Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), meeting USP/EP pharmacopeial specifications.
Apixaban is an oral anticoagulant that directly inhibits Factor Xa, used to prevent and treat deep vein thrombosis (DVT), pulmonary embolism (PE), and for stroke prevention in patients with non-valvular atrial fibrillation. Our API is subjected to rigorous quality assurance and validated manufacturing processes to ensure reliability and effectiveness in pharmaceutical formulations.
Amber Lifesciences supports pharmaceutical companies, formulation developers, manufactures, exporters, shippers and traders across Asia, Europe, the Middle East, and LATAM regions, offering dependable supply chains, technical expertise, and comprehensive regulatory documentation to streamline product registration and ensure timely market access.
Storage & Transportation
Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from moisture and direct sunlight. Handle according to standard pharmaceutical storage and transport procedures.
CAS No.: | 503612-47-3 |
|---|---|
Synonym: | Eliquis, BMS-562247-01, BMS-562247 |
Mol. formula: | C25H25N5O4 |
Mol. Weight: | 459.5 g/mol |
Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.